@article{Hill2020,
abstract = {SETTING: Thirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa. OBJECTIVE: To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patients using routine laboratory records. DESIGN: Laboratory records were obtained for 195 patients with laboratory-detected rifampicin-resistant TB (RR-TB) during July–September 2016. Health facility visits identified from these data were plotted to visualise patient healthcare journeys. Data were verified by facility visits. RESULTS: In the 9 months after the index RR-TB sample was collected, patients visited a mean of 2.3 health facilities (95{\%} CI 2.1–2.6), with 9{\%} visiting ≥4 facilities. The median distance travelled by patients from rural areas (116 km, interquartile range [IQR] 50–290) was greater than for urban patients (51 km, IQR 9–140). A median of 21{\%} of patient's time was spent under the care of primary healthcare facilities: this was respectively 6{\%}, 37{\%} and 39{\%} in KZN, EC and WC. Journey patterns were generally similar within districts. Some reflected a semi-centralised model of care where patients were referred to regional hospitals; other journeys showed greater involvement of primary care. CONCLUSION: Routine laboratory data can be used to explore DR-TB patient healthcare journeys and show how the use of healthcare services for DR-TB varies in different settings.},
author = {Hill, J and Dickson-Hall, L and Grant, A D and Grundy, C and Black, J and Kielmann, K and Mlisana, K and Mitrani, L and Loveday, M and Moshabela, M and {Le Roux}, S and Jassat, W and Nicol, M and Cox, Helen},
doi = {10.5588/ijtld.19.0100},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Hill et al. - 2020 - Drug-resistant tuberculosis patient care journeys in South Africa a pilot study using routine laboratory data.pdf:pdf},
issn = {1027-3719},
journal = {The International Journal of Tuberculosis and Lung Disease},
keywords = {OA,fund{\_}not{\_}ack,original},
mendeley-tags = {OA,fund{\_}not{\_}ack,original},
month = {jan},
number = {1},
pages = {83--91},
title = {{Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data}},
url = {https://www.ingentaconnect.com/content/10.5588/ijtld.19.0100},
volume = {24},
year = {2020}
}

{"_id":"JCuFyPHKCXqboqYCJ","bibbaseid":"hill-dicksonhall-grant-grundy-black-kielmann-mlisana-mitrani-etal-drugresistanttuberculosispatientcarejourneysinsouthafricaapilotstudyusingroutinelaboratorydata-2020","authorIDs":[],"author_short":["Hill, J","Dickson-Hall, L","Grant, A D","Grundy, C","Black, J","Kielmann, K","Mlisana, K","Mitrani, L","Loveday, M","Moshabela, M","Le Roux, S","Jassat, W","Nicol, M","Cox, H."],"bibdata":{"bibtype":"article","type":"article","abstract":"SETTING: Thirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa. OBJECTIVE: To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patients using routine laboratory records. DESIGN: Laboratory records were obtained for 195 patients with laboratory-detected rifampicin-resistant TB (RR-TB) during July–September 2016. Health facility visits identified from these data were plotted to visualise patient healthcare journeys. Data were verified by facility visits. RESULTS: In the 9 months after the index RR-TB sample was collected, patients visited a mean of 2.3 health facilities (95% CI 2.1–2.6), with 9% visiting ≥4 facilities. The median distance travelled by patients from rural areas (116 km, interquartile range [IQR] 50–290) was greater than for urban patients (51 km, IQR 9–140). A median of 21% of patient's time was spent under the care of primary healthcare facilities: this was respectively 6%, 37% and 39% in KZN, EC and WC. Journey patterns were generally similar within districts. Some reflected a semi-centralised model of care where patients were referred to regional hospitals; other journeys showed greater involvement of primary care. CONCLUSION: Routine laboratory data can be used to explore DR-TB patient healthcare journeys and show how the use of healthcare services for DR-TB varies in different settings.","author":[{"propositions":[],"lastnames":["Hill"],"firstnames":["J"],"suffixes":[]},{"propositions":[],"lastnames":["Dickson-Hall"],"firstnames":["L"],"suffixes":[]},{"propositions":[],"lastnames":["Grant"],"firstnames":["A","D"],"suffixes":[]},{"propositions":[],"lastnames":["Grundy"],"firstnames":["C"],"suffixes":[]},{"propositions":[],"lastnames":["Black"],"firstnames":["J"],"suffixes":[]},{"propositions":[],"lastnames":["Kielmann"],"firstnames":["K"],"suffixes":[]},{"propositions":[],"lastnames":["Mlisana"],"firstnames":["K"],"suffixes":[]},{"propositions":[],"lastnames":["Mitrani"],"firstnames":["L"],"suffixes":[]},{"propositions":[],"lastnames":["Loveday"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Moshabela"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Le Roux"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Jassat"],"firstnames":["W"],"suffixes":[]},{"propositions":[],"lastnames":["Nicol"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Cox"],"firstnames":["Helen"],"suffixes":[]}],"doi":"10.5588/ijtld.19.0100","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Hill et al. - 2020 - Drug-resistant tuberculosis patient care journeys in South Africa a pilot study using routine laboratory data.pdf:pdf","issn":"1027-3719","journal":"The International Journal of Tuberculosis and Lung Disease","keywords":"OA,fund_not_ack,original","mendeley-tags":"OA,fund_not_ack,original","month":"jan","number":"1","pages":"83–91","title":"Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data","url":"https://www.ingentaconnect.com/content/10.5588/ijtld.19.0100","volume":"24","year":"2020","bibtex":"@article{Hill2020,\r\nabstract = {SETTING: Thirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa. OBJECTIVE: To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patients using routine laboratory records. DESIGN: Laboratory records were obtained for 195 patients with laboratory-detected rifampicin-resistant TB (RR-TB) during July–September 2016. Health facility visits identified from these data were plotted to visualise patient healthcare journeys. Data were verified by facility visits. RESULTS: In the 9 months after the index RR-TB sample was collected, patients visited a mean of 2.3 health facilities (95{\\%} CI 2.1–2.6), with 9{\\%} visiting ≥4 facilities. The median distance travelled by patients from rural areas (116 km, interquartile range [IQR] 50–290) was greater than for urban patients (51 km, IQR 9–140). A median of 21{\\%} of patient's time was spent under the care of primary healthcare facilities: this was respectively 6{\\%}, 37{\\%} and 39{\\%} in KZN, EC and WC. Journey patterns were generally similar within districts. Some reflected a semi-centralised model of care where patients were referred to regional hospitals; other journeys showed greater involvement of primary care. CONCLUSION: Routine laboratory data can be used to explore DR-TB patient healthcare journeys and show how the use of healthcare services for DR-TB varies in different settings.},\r\nauthor = {Hill, J and Dickson-Hall, L and Grant, A D and Grundy, C and Black, J and Kielmann, K and Mlisana, K and Mitrani, L and Loveday, M and Moshabela, M and {Le Roux}, S and Jassat, W and Nicol, M and Cox, Helen},\r\ndoi = {10.5588/ijtld.19.0100},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Hill et al. - 2020 - Drug-resistant tuberculosis patient care journeys in South Africa a pilot study using routine laboratory data.pdf:pdf},\r\nissn = {1027-3719},\r\njournal = {The International Journal of Tuberculosis and Lung Disease},\r\nkeywords = {OA,fund{\\_}not{\\_}ack,original},\r\nmendeley-tags = {OA,fund{\\_}not{\\_}ack,original},\r\nmonth = {jan},\r\nnumber = {1},\r\npages = {83--91},\r\ntitle = {{Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data}},\r\nurl = {https://www.ingentaconnect.com/content/10.5588/ijtld.19.0100},\r\nvolume = {24},\r\nyear = {2020}\r\n}\r\n","author_short":["Hill, J","Dickson-Hall, L","Grant, A D","Grundy, C","Black, J","Kielmann, K","Mlisana, K","Mitrani, L","Loveday, M","Moshabela, M","Le Roux, S","Jassat, W","Nicol, M","Cox, H."],"key":"Hill2020","id":"Hill2020","bibbaseid":"hill-dicksonhall-grant-grundy-black-kielmann-mlisana-mitrani-etal-drugresistanttuberculosispatientcarejourneysinsouthafricaapilotstudyusingroutinelaboratorydata-2020","role":"author","urls":{"Paper":"https://www.ingentaconnect.com/content/10.5588/ijtld.19.0100"},"keyword":["OA","fund_not_ack","original"],"metadata":{"authorlinks":{}},"downloads":0},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","creationDate":"2020-02-20T15:13:39.742Z","downloads":0,"keywords":["oa","fund_not_ack","original"],"search_terms":["drug","resistant","tuberculosis","patient","care","journeys","south","africa","pilot","study","using","routine","laboratory","data","hill","dickson-hall","grant","grundy","black","kielmann","mlisana","mitrani","loveday","moshabela","le roux","jassat","nicol","cox"],"title":"Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data","year":2020,"dataSources":["Krmt6gt9ktB2s6ARh","FdCBAxFeyKEmJd8WK","wrEvssexmuYudwQw9","9bX4N36CTXtCXNFMd"]}